A Study of SIGX1094R in Patients With Advanced Solid Tumors

Clinical trial NCT06739291 · RECRUITING

Trial details

NCT number: NCT06739291
Sponsor: Signet Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-12-12
Primary completion: 2026-10-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.